Biogen Market Cap

Biogen has a market cap or net worth of $37.49 billion as of October 30, 2026. It is the 664th most valuable company in the world and the 311th biggest in the United States. Its market cap has increased by 72.94% in one year.

Market Cap

37.49B

Enterprise Value

43.99B

1-Year Change

72.94%

Global Rank

#664

Country Rank

#311 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Biogen's market cap has increased from $617.50M to $37.49B, an increase of 5,971.28%. That is a compound annual growth rate of 15.84%.

Market Cap History

Date	Market Cap	% Change
Oct 30, 2026	37.49B	45.21%
Dec 31, 2025	25.82B	15.86%
Dec 31, 2024	22.28B	-40.57%
Dec 29, 2023	37.50B	-5.97%
Dec 30, 2022	39.88B	13.15%
Dec 31, 2021	35.24B	-6.47%
Dec 31, 2020	37.68B	-29.63%
Dec 31, 2019	53.54B	-11.69%
Dec 31, 2018	60.63B	-10.00%
Dec 29, 2017	67.37B	9.19%
Dec 30, 2016	61.70B	-9.65%
Dec 31, 2015	68.29B	-14.82%
Dec 31, 2014	80.16B	21.39%
Dec 31, 2013	66.04B	90.69%
Dec 31, 2012	34.63B	29.54%
Dec 30, 2011	26.73B	67.31%
Dec 31, 2010	15.98B	3.27%
Dec 31, 2009	15.47B	11.34%
Dec 31, 2008	13.90B	-16.78%
Dec 31, 2007	16.70B	0.70%
Dec 29, 2006	16.58B	7.90%
Dec 30, 2005	15.37B	-30.83%
Dec 31, 2004	22.22B	288.89%
Dec 31, 2003	5.71B	12.55%
Dec 31, 2002	5.08B	-51.71%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Merck & Co.	368.89B
Novartis AG	306.70B
AstraZeneca	290.07B
Amgen	251.94B
Gilead Sciences	211.70B
Novo Nordisk	175.79B
Pfizer	173.95B
Bristol-Myers Squibb Company	127.63B

Market Cap Rankings